Related Experiment Video
Updated: Mar 13, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
Type 2 diabetes mellitus might be a risk factor for mild cognitive impairment progressing to Alzheimer's disease
Wei Li1, Tao Wang1, Shifu Xiao1
1Alzheimer's Disease and Related Disorders Center; Department of Geriatric Psychiatry, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.
Background:
Mild cognitive impairment (MCI) is the prodromal stage of Alzheimer's disease (AD), so identification of the related risk factors can be helpful. Although the association between type 2 diabetes mellitus (T2DM) and these modest changes in cognition is well established, whether T2DM will promote the transformation of MCI into AD is not a unified conclusion.
Objective:
This study aims to explore the relationship between T2DM and MCI in the elderly population living in the community in Shanghai, People's Republic of China.
Methods:
A total of 197 participants were included in the study. They were screened for T2DM, hyperlipidemia, traumatic brain injury, and family history of dementia. The Mini-Mental State Examination and the Montreal Cognitive Assessment were used to assess cognitive function. The diagnosis of AD was made according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, whereas the diagnosis of MCI was made according to Petersen's criteria. Then, we investigated the relation between T2DM and MCI.
Results:
A total of 82 (41.6%) participants had no cognitive impairment, 82 (41.6%) participants had MCI, and 33 (16.8%) participants had AD. Multivariate logistic regression models demonstrated that T2DM was a risk factor for AD (odds ratio =49.723, 95% CI =21.173-111.987).
Conclusion:
T2DM might be a risk factor for MCI progressing into AD.
Insights
Type 2 diabetes mellitus (T2DM) is a significant risk factor for Alzheimer's disease (AD) progression in older adults. This study found T2DM strongly associated with increased odds of developing AD from mild cognitive impairment (MCI).
Area of Science:
- Neuroscience
- Gerontology
- Endocrinology
Background:
- Mild cognitive impairment (MCI) is a precursor to Alzheimer's disease (AD).
- Type 2 diabetes mellitus (T2DM) is linked to cognitive changes, but its role in MCI progression to AD is unclear.
Purpose of the Study:
- To investigate the relationship between T2DM and MCI in elderly Shanghai residents.
- To determine if T2DM exacerbates cognitive decline in the elderly.
Main Methods:
- 197 elderly participants were assessed for T2DM, hyperlipidemia, brain injury, and dementia history.
- Cognitive function evaluated using Mini-Mental State Examination and Montreal Cognitive Assessment.
- Diagnoses based on DSM-IV for AD and Petersen's criteria for MCI.
Main Results:
- 41.6% had no cognitive impairment, 41.6% had MCI, and 16.8% had AD.
- Multivariate logistic regression showed T2DM as a significant risk factor for AD (OR=49.723).
Conclusions:
- T2DM may increase the risk of mild cognitive impairment progressing to Alzheimer's disease.
- Findings highlight T2DM as a critical factor in AD pathogenesis.
More Related Videos
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
Related Concept Videos
Psychoneuroimmunology: Diabetes and Cancer
Diabetes Mellitus: Type 2 and Gestational
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Dementia
The progression of dementia is generally gradual....
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...